Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: dermal
Type of information:
calculation (if not (Q)SAR)
Remarks:
Based on Chromium 3+ ions
Adequacy of study:
key study
Study period:
Single dose
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
accepted calculation method
Justification for type of information:
There is evidence that the biological effects of chromium salts is based on the dissociated chromium ion.
The substance dissociates in water or biological systems

Data source

Reference
Reference Type:
publication
Title:
Safety and toxicological evaluation of a novel niacin-bound chromium (III) complex
Author:
Shara M, Yasmin T, Kincaid AE, et al
Year:
2005
Bibliographic source:
J Inorg Biochem. 2005;99(11):2161–2813.

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 402 (Acute Dermal Toxicity)
GLP compliance:
not specified
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
Chromium triformate
EC Number:
248-230-2
EC Name:
Chromium triformate
Cas Number:
27115-36-2
Molecular formula:
Cr(CHO2)3
IUPAC Name:
chromium triformate
Test material form:
solid: particulate/powder
Specific details on test material used for the study:
Various chromium salts, including nicotinate used for the calculation

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male

Administration / exposure

Type of coverage:
not specified
Vehicle:
not specified
Duration of exposure:
24 hours
Doses:
2000 mg/kg
Control animals:
not specified

Results and discussion

Effect levels
Sex:
male
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.
Mortality:
No
Clinical signs:
other: Slight irritation
Gross pathology:
Not specified

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
It has been demonstrated that systemic toxicity to chromium 3+ is based on the dissociated ions.
The LD50 of chromium 3+ is considered > 600 mg/kg as Chromium 3+ based on different salts